Stocktoria
Xtant Medical Holdings, Inc. XTNT
NYSE American · XASE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2010-06-30
Xtant Medical Holdings, Inc. statistics & valuation
Market cap$63.1M
P / E12.7×
P / S0.5×
P / B1.2×
P / FCF6.2×
Net margin3.7%
Return on equity9.8%
FCF margin7.6%
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 62.9% | 58.2% | 60.8% | 55.4% | 58.8% | 64.5% | 65.7% | 60.2% | 60.6% | 69.2% |
| Operating margin | 5.4% | -10.3% | -11.1% | -11.7% | -7.0% | -1.4% | -3.5% | -83.2% | -45.8% | -8.4% |
| Net margin | 3.7% | -14.0% | 0.7% | -14.6% | -8.8% | -13.2% | -12.7% | -97.1% | -63.4% | -21.7% |
| FCF margin | 7.6% | -13.7% | -12.0% | -12.3% | -3.0% | -4.3% | -2.0% | 0.8% | — | — |
| Return on assets | 5.3% | -17.5% | 0.7% | -14.1% | -8.9% | -16.9% | -19.0% | -151.0% | -49.6% | -13.5% |
| Return on equity | 9.8% | -38.3% | 1.3% | -24.8% | -15.7% | -48.4% | 18.6% | 160.1% | 89.3% | 275.6% |
| Debt / equity | 0.22× | 0.51× | 0.33× | 0.28× | 0.38× | — | -1.72× | -1.78× | -2.35× | -16.85× |
| Current ratio | 2.65 | 2.35 | 2.82 | 3.24 | 4.00 | 1.22 | 3.43 | 2.88 | 1.54 | 1.57 |
Source: SEC EDGAR filings · CIK 0001453593 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.